MBMilad Baradaran‐Ghahfarokhi

Milad Baradaran‐Ghahfarokhi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Milad Baradaran‐Ghahfarokhi has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Characterization of a 0.5 × 0.5 mm plastic scintillating detector for small field dosimetry: Its performance and comparison with other commercially available plastic scintillating detectors

    by Milad Baradaran‐Ghahfarokhi, Beshoi Grees, Annie Cooney, Erica Northern, George Ding, Guozhen Luo, Kenneth Homann

    Background: Lack of an ideal detector for small field dosimetry has led to the development of many new types of detectors. Recent studies have shown that plastic scintillation detectors (PSDs) provide favorable dosimetric characteristics, such as minimal volume averaging and fluence perturbation effects, real time response rates, high signal to noise ratio (SNR), and independence to temperature, energy spectrum, dose rate, and irradiation direction, in the field of small field dosimetry, largely due to their small size and water‐equivalent composition materials, which eliminates the need for certain correction factors. Purpose: The goal of this study was to evaluate a new 0.5 × 0.5 mm 2 PSD (called in this study Medscint0.5), with detailed uncertainty analysis, for its suitability in small field dosimetry and in comparison, to other commercially available PSDs. Methods: This detector characterization was performed for small field output factors, pre‐ and post‐ irradiation leakage, short‐term repeatability, angular dependency, dose rate and energy dependency, dose response linearity, and temperate dependency. The small field output factors measured with this detector were also evaluated to determine if any correction factors were needed for extremely small fields. Results: The Medscint0.5 showed negligible leakage (< 0.1%) and short‐term repeatability (< 0.1% response deviations), similar to other commercially available PSDs. It also demonstrated comparable dose rate (< 0.47%) and dose response linearity (< 0.73%) to an ion chamber. Moreover, it also showed excellent angular (< 0.30%) and temperature independence (< 0.38%) relative to other commercially available PSDs. Stereotactic cone factor measurements showed good agreement (< 1.10%) with MC for all SRS cone sizes for both 6 and 10 MV FFF beams. The total uncertainty for absolute dosimetry using this detector was found to be ∼1.1% at one standard deviation from the mean. The uncertainty can be reduced to 0.8% at one standard deviation when this detector is used for relative small field dosimetry, that is, field output measurements. Conclusion: The latest small size Medscint0.5 detector is suitable for small field dosimetry with its unique advantage in measuring field output factors without need of any correction factor even in measuring small circular fields down to 4 mm diameter.

  • A Monte Carlo based analytic model of the in-room neutron ambient dose equivalent for a Mevion gantry-mounted passively scattered proton system

    by Milad Baradaran-Ghahfarokhi, Francisco Reynoso, Arash Darafsheh, Baozhou Sun, Michael T Prusator, Sasa Mutic, Tianyu Zhao

    The goal of this study was to develop a Monte Carlo (MC)-based analytical model that can predict the in-room ambient dose equivalent from a Mevion gantry-mounted passively scattered proton system. The Mevion S250 and treatment vault were simulated using the MCNPX MC code. The results of the in-room neutron dose measurements, using an FHT 762 WENDI-II detector, were employed to benchmark the MC-derived values. After tuning the MCNPX MC code, for the same beam delivery parameters, the code was used to calculate the neutron spectra and ambient dose equivalent in the vault and at varying angles from the isocenter. Then, based on the calculations, an analytical model was reconstructed and data were fitted to derive the model parameters at 95% confidence intervals (CI). The MCNPX codes were tuned to within about 19% of the measured values for most of the measurements in the vault. For the maze, up to 0.08 mSv Gy −1 discrepancies were found between the experimental measurements and MCNPX calculated results. The analytical model showed up to 18% discrepancy for distances between 100 and 600 cm from the isocenter compared to the MC calculations. The model may underestimate the neutron ambient dose equivalent up to 21% for distances less than 100 cm from the isocenter. The proposed analytical model can be used to estimate the contribution of the secondary neutron dose from the Mevion S250 for the design of local shielding inside the proton therapy treatment vault.


  • A novel approach in electron beam radiation therapy of lips carcinoma: A Monte Carlo study

    by Parvaneh Shokrani, Milad Baradaran‐Ghahfarokhi, Maryam Khorami Zadeh

    Purpose:: Squamous cell carcinoma (SCC) is commonly treated by electron beam radiotherapy (EBRT) followed by a boost via brachytherapy. Considering the limitations associated with brachytherapy, in this study, a novel boosting technique in EBRT of lip carcinoma using an internal shield as an internal dose enhancer tool (IDET) was evaluated. An IDET is referred to a partially covered internal shield located behind the lip. It was intended to show that while the backscattered electrons are absorbed in the portion covered with a low atomic number material, they will enhance the target dose in the uncovered area.Methods:: Monte‐Carlo models of 6 and 8 MeV electron beams were developed using BEAMnrc code and were validated against experimental measurements. Using the developed models, dose distributions in a lip phantom were calculated and the effect of an IDET on target dose enhancement was evaluated. Typical lip thicknesses of 1.5 and 2.0 cm were considered. A 5 × 5 cm2 of lead covered by 0.5 cm of polystyrene was used as an internal shield, while a 4 × 4 cm2 uncovered area of the shield was used as the dose enhancer.Results:: Using the IDET, the maximum dose enhancement as a percentage of dose at dmax of the unshielded field was 157.6% and 136.1% for 6 and 8 MeV beams, respectively. The best outcome was achieved for lip thickness of 1.5 cm and target thickness of less than 0.8 cm. For lateral dose coverage of planning target volume, the 80% isodose curve at the lip‐IDET interface showed a 1.2 cm expansion, compared to the unshielded field.Conclusions:: This study showed that a boost concomitant EBRT of lip is possible by modifying an internal shield into an IDET. This boosting method is especially applicable to cases in which brachytherapy faces limitations, such as small thicknesses of lips and targets located at the buccal surface of the lip.


  • EchoSeed Model 6733 Iodine‐125 brachytherapy source: Improved dosimetric characterization using the MCNP5 Monte Carlo code

    by M. A. Mosleh‐Shirazi, K. Hadad, R. Faghihi, M. Baradaran‐Ghahfarokhi, Z. Naghshnezhad, A. S. Meigooni

    This study primarily aimed to obtain the dosimetric characteristics of the Model 6733 125I seed (EchoSeed) with improved precision and accuracy using a more up‐to‐date Monte‐Carlo code and data (MCNP5) compared to previously published results, including an uncertainty analysis. Its secondary aim was to compare the results obtained using the MCNP5, MCNP4c2, and PTRAN codes for simulation of this low‐energy photon‐emitting source. The EchoSeed geometry and chemical compositions together with a published 125I spectrum were used to perform dosimetric characterization of this source as per the updated AAPM TG‐43 protocol. These simulations were performed in liquid water material in order to obtain the clinically applicable dosimetric parameters for this source model. Dose rate constants in liquid water, derived from MCNP4c2 and MCNP5 simulations, were found to be 0.993 cGyh−1 U−1 (±1.73%) and 0.965 cGyh−1 U−1 (±1.68%), respectively. Overall, the MCNP5 derived radial dose and 2D anisotropy functions results were generally closer to the measured data (within ±4%) than MCNP4c and the published data for PTRAN code (Version 7.43), while the opposite was seen for dose rate constant. The generally improved MCNP5 Monte Carlo simulation may be attributed to a more recent and accurate cross‐section library. However, some of the data points in the results obtained from the above‐mentioned Monte Carlo codes showed no statistically significant differences. Derived dosimetric characteristics in liquid water are provided for clinical applications of this source model.